Thimble Point Acquisition Corp Cl A (THMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | THMA | TPST | DERM | ||
| Company | Thimble Point Acquisition Corp Cl A | Tempest Therapeutics Inc | Journey Medical Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.15 | 3.75 | 3.68 | ||
| High | 9.33 | 3.79 | 3.74 | ||
| Low | 9.15 | 3.60 | 3.51 | ||
| Last | 9.30 | 3.73 | 3.55 | ||
| Change | +0.18 | +0.04 | -0.14 | ||
| % Change | +1.93% | +1.08% | -3.79% | ||
| Volume | 700 | 213,300 | 51,300 | ||
| 20-Day Average Volume | 281,600 | 430,255 | 109,930 | ||
| Previous Close | 9.12 | 3.69 | 3.69 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 9.83 | 3.49 | 3.73 | ||
| 20-Day Raw Stochastic | 26.62% | 59.79% | 20.79% | ||
| 20-Day Relative Strength | 23.36% | 51.18% | 47.28% | ||
| Weighted Alpha | -9.39 | -76.77 | +26.75 | ||
| Today's Opinion | N/A | 8% Sell | 56% Sell | ||
| Previous Opinion | N/A | 16% Sell | 48% Sell | ||
| Last Month's Opinion | N/A | 48% Buy | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.34% since 11/26/21 | +8.43% since 04/29/24 | +6.61% since 04/29/24 | ||
| Low | 9.01 on 12/02/21 | 3.39 on 04/30/24 | 3.34 on 04/30/24 | ||
| High | 10.10 on 11/29/21 | 3.79 on 05/06/24 | 3.74 on 05/06/24 | ||
| 1-Month | |||||
| %Chg | -6.72% since 11/03/21 | +0.27% since 04/05/24 | -3.53% since 04/05/24 | ||
| Low | 9.01 on 12/02/21 | 3.06 on 04/19/24 | 3.27 on 04/29/24 | ||
| High | 10.10 on 11/29/21 | 4.18 on 04/08/24 | 4.64 on 04/12/24 | ||
| 3-Month | |||||
| %Chg | -6.06% since 09/03/21 | -9.69% since 02/06/24 | -18.76% since 02/06/24 | ||
| Low | 9.01 on 12/02/21 | 3.03 on 03/04/24 | 2.85 on 03/25/24 | ||
| High | 10.10 on 11/29/21 | 6.00 on 04/02/24 | 5.05 on 02/12/24 | ||
| 6-Month | |||||
| %Chg | -4.12% since 06/03/21 | +20.32% since 11/06/23 | +9.23% since 11/06/23 | ||
| Low | 9.01 on 12/02/21 | 2.76 on 11/08/23 | 2.85 on 03/25/24 | ||
| High | 10.10 on 11/29/21 | 6.00 on 04/02/24 | 8.11 on 12/20/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 76,361 | 81,981 | 73,549 | ||
| Shares Outstanding, K | 8,211 | 22,217 | 19,932 | ||
| Annual Sales | 0 | 0 | 79,180,000 | ||
| Annual Net Income | 0 | -29,490,000 | -3,850,000 | ||
| Last Quarter Sales | 0 | 0 | 15,260,000 | ||
| Last Quarter Net Income | 5,830,000 | -7,490,000 | -2,140,000 | ||
| 60-Month Beta | N/A | -1.65 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.34 on 03/19/24 | -0.12 on 03/21/24 | ||
| Latest Earnings Date | N/A | 05/08/24 | 05/27/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||